Don't have Telegram yet? Try it now!
https://icmphilly.com/questions/do-immunomodulatory-disease-modifying-medications-e-g-methotrexate-or-antitumor-necrosis-factor-anti-tnf-agents-need-to-be-withheld-preoperatively-to-reduce-the-risk-for-subsequent-surgical-site/
Do immunomodulatory disease-modifying medications (e.g., methotrexate or antitumor necrosis factor (anti-TNF) agents) need to be withheld preoperatively to reduce the risk for subsequent surgical site infection/periprosthetic joint infection (SSI/PJI)?